Interlaminar Device Market Size

  • Report ID: 3974
  • Published Date: Nov 20, 2025
  • Report Format: PDF, PPT

Interlaminar Device Market Outlook:

Interlaminar Device Market size was over USD 693.15 million in 2025 and is anticipated to cross USD 1.26 billion by 2035, growing at more than 6.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of interlaminar device is estimated at USD 731.83 million.

The reason behind the growth is the surging rate of minimally invasive spine surgeries. For instance, to treat spinal conditions such as spinal stenosis, an interlaminar device is frequently used to reduce pain and offer the required support to the spine. According to the data published in 2020, more than 300 million surgeries are performed each year.

The growing advancements in spine surgery technologies across the globe are believed to fuel market growth. For instance, newer and safer techniques are being developed which result in shorter stays in hospitals and are known to be more effective.


Interlaminar Device Market

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of interlaminar device is estimated at USD 731.83 million.

The global interlaminar device market size was more than USD 693.15 million in 2025 and is anticipated to grow at a CAGR of over 6.2%, reaching USD 1.26 billion revenue by 2035.

By 2035, North America is expected to command a 38% share of the interlaminar device market, supported by the rising adoption of interlaminar devices in the region.

Key players in the market include NuVasive, Inc., Zimmer Biomet, Life Spine, Inc., Xtant Medical, Alphatec Holdings, Inc., Amedica Corporation, Paradigm Health System, Bioventus LLC, Medical Device Business Services, Inc., Meditech Spine, LLC.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos